The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy
Open accessAbstract
PURPOSE: To compare the anatomic and functional efficacy and safety of half-dose photodynamic therapy (PDT) versus high-density subthreshold micropulse laser (HSML) treatment in patients with chronic central serous chorioretinopathy (cCSC). DESIGN: Open-label, multicenter, randomized controlled clinical trial. PARTICIPANTS: Patients with cCSC whose disease had to be confirmed by both clinical characteristics and findings on multimodal imaging. METHODS: Eligible patients were randomized in a 1:1 allocation ratio. Treatment was evaluated during a follow-up visit, and the same treatment was repeated in patients who still demonstrated subretinal fluid (SRF). MAIN OUTCOME MEASURES: The primary end point was the complete disappearance of SRF at the first evaluation visit at 6 to 8 weeks after treatment. As a secondary outcome measure, we assessed this anatomic result at the final evaluation visit at 7 to 8 months after treatment. Other secondary outcomes covered functional improvement and included change in best-corrected visual acuity (BCVA; measured in Early Treatment Diabetic Retinopathy Study [ETDRS] letters), retinal sensitivity (measured using microperimetry), and vision-related quality of life using a validated questionnaire. RESULTS: Between November 2013 and September 2016, 179 patients were included: 89 patients were assigned randomly to half-dose PDT, and 90 were assigned randomly to HSML treatment. At their first evaluation visit, SRF had resolved in 51.2% and 13.8% of patients, respectively (P < 0.001). At their final evaluation visit, a significantly higher percentage of PDT-treated patients demonstrated no SRF (67.2% vs. 28.8%; P < 0.001). Moreover, at the first evaluation visit, the PDT-treated patients showed a significantly higher increase in BCVA (+4.60±6.62 ETDRS letters vs. +1.39±8.99 ETDRS letters; P = 0.011), and a significantly higher increase in retinal sensitivity on microperimetry (+2.01±3.04 dB vs. +0.92±3.65 dB; P = 0.046); however, the improvement in vision-related quality of life was similar (score of +2.87±8.35 vs. +2.56±7.36, respectively; P = 0.800). CONCLUSIONS: Half-dose PDT is superior to HSML for treating cCSC, leading to a significantly higher proportion of patients with complete resolution of SRF and functional improvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of the 25-list-item National Eye Institute Visual Function Questionnaire
Mangione, C. M. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.7.1050 · Cited by 2,230
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
Daruich, A., Matet, A., Dirani, A., Bousquet, E., Zhao, M., Farman, N., Jaisser, F., & Behar-Cohen, F. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.05.003 · Cited by 989
VERTEPORFIN ROUNDTABLE 2000 AND 2001 PARTICIPANTS, T. O. A.-R. M. D. W. P. T. (. S. G. P. I. (2002) · Retina · doi:10.1097/00006982-200202000-00003 · Cited by 246
CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
IIDA, T., YANNUZZI, L. A., SPAIDE, R. F., BORODOKER, N., CARVALHO, C. A., & NEGRÃO, S. (2003) · RETINA · doi:10.1097/00006982-200302000-00001 · Cited by 215
Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
Breukink, M. B., Dingemans, A. J., den Hollander, A. I., Keunen, J. E., MacLaren, R. E., Fauser, S., Querques, G., Hoyng, C. B., Downes, S. M., & Boon, C. J. (2016) · Clinical Ophthalmology · doi:10.2147/opth.s115685 · Cited by 158
Self-citationInterventions for central serous chorioretinopathy: a network meta-analysis
Salehi, M., Wenick, A. S., Law, H. A., Evans, J. R., & Gehlbach, P. L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011841.pub2 · Cited by 146
de Jong, E. K., Breukink, M. B., Schellevis, R. L., Bakker, B., Mohr, J. K., Fauser, S., KEUNEN, J. E. E., Hoyng, C. B., den Hollander, A. I., & Boon, C. J. F. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.09.026 · Cited by 137
Self-citationChan, W., Lam, D. S. C., Lai, T. Y. Y., Yuen, K. S. C., Liu, D. T. L., Chan, C. K. M., & Chen, W.-Q. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00462-8 · Cited by 76
van Dijk, E. H. C., Schellevis, R. L., van Bergen, M. G. J. M., Breukink, M. B., Altay, L., Scholz, P., Fauser, S., Meijer, O. C., Hoyng, C. B., den Hollander, A. I., et al. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.0245 · Cited by 76
Self-citationBreukink, M. B., Downes, S. M., Querques, G., van Dijk, E. H. C., den Hollander, A. I., Blanco-Garavito, R., KEUNEN, J. E. E., Souied, E. H., MacLaren, R. E., Hoyng, C. B., et al. (2015) · Trials · doi:10.1186/s13063-015-0939-z · Cited by 51
Self-citation
Cited by
Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions
Correia, J. H., Rodrigues, J. A., Pimenta, S., Dong, T., & Yang, Z. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091332 · Cited by 1,266
Central serous chorioretinopathy: Towards an evidence-based treatment guideline
van Rijssen, T. J., van Dijk, E. H. C., Yzer, S., Ohno-Matsui, K., Keunen, J. E. E., Schlingemann, R. O., Sivaprasad, S., Querques, G., Downes, S. M., Fauser, S., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.003 · Cited by 478
Self-citationSpaide, R. F., Gemmy Cheung, C. M., Matsumoto, H., Kishi, S., Boon, C. J. F., van Dijk, E. H. C., Mauget-Faysse, M., Behar-Cohen, F., Hartnett, M. E., Sivaprasad, S., et al. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100973 · Cited by 372
Self-citation
Metadata
- Authors
- van Dijk, E. H. C., Fauser, S., Breukink, M. B., Blanco-Garavito, R., Groenewoud, J. M. M., Keunen, J. E. E., Peters, P. J. H., Dijkman, G., Souied, E. H., MacLaren, R. E., Querques, G., Downes, S. M., Hoyng, C. B., & Boon, C. J. F.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 125
- Issue
- 10
- Pages
- 1547-1555
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2803624845
- Cited by
- 351
- References
- 11
- FWCI
- 24.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy. https://app.cochat.ai/papers/10.1016/j.ophtha.2018.04.021
- The paper
- van Dijk, E. H. C., Fauser, S., Breukink, M. B., Blanco-Garavito, R., Groenewoud, J. M. M., Keunen, J. E. E., Peters, P. J. H., Dijkman, G., Souied, E. H., MacLaren, R. E., Querques, G., Downes, S. M., Hoyng, C. B., & Boon, C. J. F. (2018). Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy. Ophthalmology. https://doi.org/10.1016/j.ophtha.2018.04.021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.